Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry.
BackgroundPatients with diabetes mellitus are at an increased risk for adverse clinical events following percutaneous coronary MUSTARD interventions (PCI).However, the clinical impact of diabetes mellitus (DM) on second-generation drug-eluting stent (DES) implantation is not well-known.The aim of the current analysis was to examine the clinical imp